Latest Articles

Publication Date
All News Scientific
Overcoming the Complexity of Total Laparoscopic Hysterectomy and Bilateral Salpingo-Oophorectomy in a Patient With Uterine Didelphys and Dual Endometrial Pathology: A Surgical Approach in a Complex Anatomical Variant - Cureus

Overcoming the Complexity of Total Laparoscopic Hysterectomy and Bilateral Salpingo-Oophorectomy in a Patient With Uterine Didelphys and Dual Endometrial Pathology: A Surgical Approach in a Complex Anatomical Variant Cureus

Published: Oct. 22, 2025, 3:01 a.m.
Read Full Article
Adiposity, Metabolites Linked to Endometrial Cancer - bioengineer.org

Adiposity, Metabolites Linked to Endometrial Cancer bioengineer.org

Published: Oct. 21, 2025, 2:27 p.m.
Read Full Article
Adiposity, Metabolites Linked to Endometrial Cancer - Bioengineer.org

Adiposity, Metabolites Linked to Endometrial Cancer Bioengineer.org

Published: Oct. 21, 2025, 2:27 p.m.
Read Full Article
Adiposity, Metabolites Linked to Endometrial Cancer - BIOENGINEER.ORG

Adiposity, Metabolites Linked to Endometrial Cancer BIOENGINEER.ORG

Published: Oct. 21, 2025, 2:27 p.m.
Read Full Article
Comparison of identification of sentinel lymph nodes between ICG vs methylene blue in v notes staging surgery for endometrial cancer - BMC Surgery

Comparison of identification of sentinel lymph nodes between ICG vs methylene blue in v notes staging surgery for endometrial cancer BMC Surgery

Published: Oct. 21, 2025, 11:10 a.m.
Read Full Article
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer - Dana-Farber Cancer Institute

Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer Dana-Farber Cancer Institute

Published: Oct. 21, 2025, 9 a.m.
Read Full Article
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace

Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace

Published: Oct. 21, 2025, 5:15 a.m.
Read Full Article
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer - Pharmacy Times

KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer Pharmacy Times

Published: Oct. 21, 2025, 3:34 a.m.
Read Full Article
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal

Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal

Published: Oct. 20, 2025, 9:33 p.m.
Read Full Article
Endometrial Ablation as a Safe Treatment for Adenomyosis-Related Abnormal Uterine Bleeding in Women with Cerebral Infarction: A Case Report - Frontiers

Endometrial Ablation as a Safe Treatment for Adenomyosis-Related Abnormal Uterine Bleeding in Women with Cerebral Infarction: A Case Report Frontiers

Published: Oct. 20, 2025, 9 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!